Related Experiment Videos
Risk factors for coronary heart disease in perspective. European intervention trials
Insights
Major risk factors for heart attack include high blood pressure, smoking, and abnormal lipids. Managing these factors is key, but caution is advised with drug treatments for moderate risks.
Area of Science:
- Cardiology
- Preventive Medicine
- Epidemiology
Background:
- Dominant risk factors for myocardial infarction and sudden coronary death include hypertension, smoking, and dyslipidemia.
- The interplay between these risk factors significantly modifies their individual impact.
- Geographical variations exist, with stroke being more prevalent in hypertensive patients in low-cholesterol regions, while myocardial infarction is more common in Western countries.
Purpose of the Study:
- To analyze the impact of combined risk factors on cardiovascular events.
- To evaluate the effectiveness and considerations for intervention studies in coronary heart disease.
- To compare results from multiple risk factor intervention trials.
Main Methods:
- Comparative analysis of intervention studies, including the Oslo trial, WHO Multifactorial Trial, and Göteborg Multiple Risk Factor Intervention Trial.
- Review of data concerning the correlation between risk factor changes and coronary heart disease incidence.
- Consideration of drug side effects and patient risk stratification.
Main Results:
- The effectiveness of interventions in coronary heart disease trials is influenced by the overall risk factor profile.
- Drug treatment for individuals with moderately increased risk factors requires careful consideration.
- Observed effects on coronary heart disease incidence across trials broadly correlated with modifications in risk factors.
Conclusions:
- Intervention strategies must account for the complex interplay of cardiovascular risk factors.
- Drug interventions may yield varying effects on mortality and morbidity depending on the modality and patient population.
- Caution is recommended regarding widespread drug treatment for individuals with moderately elevated risk factors.
Abstract:
High blood pressure, smoking, and lipid abnormalities are the dominating risk factors for myocardial infarction and sudden coronary death. The influence of one risk factor is markedly modified by other risk factors. In countries with low cholesterol levels, myocardial infarction and sudden coronary death may be uncommon, whereas stroke becomes a relatively important sequelae in patients with severe hypertension. However, in most western countries myocardial infarction and sudden coronary death are more common than stroke, especially in patients with moderate blood pressure elevations. The results of intervention studies in coronary heart disease must be viewed in the light of the general risk factor pattern. The side effects of drugs should be considered since large-scale intervention is often required in order to save a relatively small number of lives. In those at high risk from cardiovascular complications, certain drugs are possibly more effective than others in preventing the more serious end points. The results of the Oslo trial are compared with those of the WHO Multifactorial Trial, which randomized factories to intervention and control (nonintervention) in England, Belgium, and Italy, and also with the Göteborg Multiple Risk Factor Intervention Trial. A comparison of the different trials might indicate caution with respect to drug treatment in people with moderately increased risk factors. The effect of the incidence of coronary heart disease in different trials correlated broadly with changes in risk factors. Varying effects on mortality and morbidity might be found for different treatment modalities.